Blog
RSS FeedPosted by Michael Wonder on 21 Feb 2021
Ontario makes commitment to funding CF drugs after approval process completed
19 February 2021 - Ontario’s Health Minister Christine Elliott says life-saving cystic fibrosis medications that are inching their way through ...
Posted by Michael Wonder on 18 Feb 2021
Fresenius Kabi Canada launches Idacio (adalimumab injection) a biosimilar to Humira (adalimumab) for the treatment of multiple chronic inflammatory conditions
18 February 2021 - Biosimilars offer patients access to affordable, meaningful medicines ...
Posted by Michael Wonder on 18 Feb 2021
HLS Therapeutics provides update on private and public payer reimbursement for Vascepa
16 February 2021 - Active negotiations have also begun with the pan-Canadian Pharmaceutical Alliance for reimbursement of Vascepa by publicly funded ...
Posted by Michael Wonder on 11 Feb 2021
An institutional ethnographic analysis of public and patient engagement activities at a national health technology assessment agency
9 February 2021 - The practice of public and patient engagement in health technology assessment has spread worldwide, yet gaps in ...
Posted by Michael Wonder on 11 Feb 2021
Cystic fibrosis advocate asks P.E.I. to fast-track coverage of new 'mind-blowing' drug
10 February 2021 - ‘It’s the closest thing we’ve ever had to a cure’. ...
Posted by Michael Wonder on 10 Feb 2021
New drugs entering Canada at steady rate over past 5 years - Canada still among top 10 OECD countries in terms of access to new drugs
10 February 2021 - The latest edition of the Patented Medicine Prices Review Board Meds Entry Watch reports that 40 new-to-Canada ...
Posted by Michael Wonder on 07 Feb 2021
Patient and public involvement in health technology assessment: update of a systematic review of international experiences
5 February 2021 - This paper summarises the current evidence on patient and public involvement in health technology assessment in order ...
Posted by Michael Wonder on 24 Jan 2021
Canada’s drug makers rattle their sabers over a government plan to control medicine spending
21 January 2021 - A majority of pharmaceutical executives in Canada say new regulations designed to cut prescription drug spending ...
Posted by Michael Wonder on 21 Jan 2021
Industry pooling helps maintain affordability of high cost drugs despite significant inflationary pressures
21 January 2021 - In 2019, the Canadian Drug Insurance Pooling Corporation's (CDIPC) high-cost drug sharing framework provided coverage to ...
Posted by Michael Wonder on 09 Jan 2021
Health Canada postpones overhaul of drug pricing for 6 months
8 January 2021 - Changes meant to bring down price of prescription drugs pushed to 1 July 2021. ...
Posted by Michael Wonder on 04 Jan 2021
ALS patients and advocates say Canada needs better access to new treatments
3 January 2020 - 'The clock is ticking for us,' says a Niagara man who has ALS, and has joined the ...
Posted by Michael Wonder on 30 Nov 2020
Canada to Trump: you can't take our prescription drugs
30 November 2020 - Canada is putting the kibosh on President Donald Trump's efforts to lower drug prices by importing ...
Posted by Michael Wonder on 29 Nov 2020
Canada bans mass exports of prescription drugs
29 November 2020 - Canada has banned the export of some prescription medicines in order to prevent a shortage in ...
Posted by Michael Wonder on 15 Nov 2020
Drug makers offer Canada 1 billion dollars to scrap some pending pricing rules
16 November 2020 - The pharmaceutical industry has made a last-ditch C$1 billion ($761 million) proposal to the Canadian government ...
Posted by Michael Wonder on 10 Nov 2020
Manufacturer moves to bring 'life-changing' cystic fibrosis drugs to Canada
10 November 2020 - A pharmaceutical company says it's taking steps to bring cystic fibrosis drugs to Canada in a ...